- US-listed companies
- Cellebrite DI Ltd.
- Income statement
Cellebrite DI Ltd. (CLBT) Income statement
Market cap
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 246 | 271 | 325 | 401 |
| Revenue growth (%) | - | - | ||
| Cost of revenue | 43 | 51 | 53 | 63 |
| Gross profit | 204 | 220 | 272 | 339 |
| Gross margin (%) | ||||
| Research & development | 66 | 81 | 84 | 98 |
| Operating margin (%) | ||||
| Operating expenses | 190 | 219 | 239 | 282 |
| Operating income | 14 | 1 | 33 | 57 |
| Income before tax | 82 | 121 | -76 | -276 |
| Pretax margin (%) | 33.4 | 44.6 | -23.2 | -68.8 |
| Provision for income taxes | 11 | -0 | 6 | 7 |
| Effective tax rate (%) | ||||
| Net income | 71 | 121 | -81 | -283 |
| Net income margin (%) | ||||
| Earnings per share | 0.49 | 0.64 | -0.43 | -1.35 |
| Diluted EPS | 0.44 | 0.59 | -0.43 | -1.35 |
| EBITDA | ||||
| EBITDA margin (%) |